Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 1;45(2):282-284.
doi: 10.1097/FTD.0000000000001072. Epub 2023 Jan 10.

Tenofovir Plasma Trough Concentrations in People Living with HIV Treated with Tenofovir Disoproxyl Fumarate: Antiretroviral Class or Individual Drug Effect?

Dario Cattaneo  1 , Stefano Bonora  2 , Paola Meraviglia  3 , Stefania Vimercati  4 , Spinello Antinori  3 , Cristina Gervasoni  3
Affiliations

Tenofovir Plasma Trough Concentrations in People Living with HIV Treated with Tenofovir Disoproxyl Fumarate: Antiretroviral Class or Individual Drug Effect?

Dario Cattaneo et al. Ther Drug Monit. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Kauppinen KJ, Aho I, Sutinen J. Switching from tenofovir alafenamide to tenofovir disoproxil fumarate improves lipid profile and protects from weight gain. AIDS. 2022;36:1337–1344.
    1. Cattaneo D, Minisci D, Baldelli S, et al. Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF. J Acquir Immune Defic Syndr. 2018;77:86–92.
    1. Cattaneo D, Fusi M, Micheli V, et al. Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens. AIDS. 2021;35:2551–2553.
    1. Tong L, Phan TK, Robinson KL, et al. Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro. Antimicrob Agents Chemother. 2007;51:3498–3504.
    1. Begley R, Das M, Zhong L, et al. Pharmacokinetics of tenofovir alafenamide when coadministered with other HIV antiretrovirals. J Acquir Immune Defic Syndr. 2018;78:465–472.

MeSH terms